NCT06140953CompletedPhase 2
Benefits of Trimetazidine in MASLD Patients
Evaluation of Potential Benefits of Trimetazidine in the Management of Patients With Metabolic Associated Steatotic Liver Disease (MASLD)
Source: ClinicalTrials.gov · Last updated 11 Jul 2025
Brief summary (registry, in English)
Objective of this study is to determine the clinical benefits of trimetazidine in improvement of MASLD
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 26 Oct 2023
- Start date
- 10 Dec 2023
- Primary completion date
- 1 Jun 2024
- Lead sponsor
- October 6 University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06140953
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 60
- From 10 Dec 2023 to the primary completion date, 1 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- drug-induced injury, hepatitis C, Wilson disease).
Lab values
- Trimetazidine contraindications (Parkinson's disease, parkinsonian symptoms, tremors, severe renal impairment), patients on statins, sodium glucose transporter 2 inhibitors (SGLT2), glucagon-like peptide 1(GLP1) were among the other exclusion criteria
Age
- Additional exclusion criteria covered ages below 18 years, pregnancy. decompensated cirrhosis, portal hypertension, hepatocellular carcinomas.
Other
- alternative steatosis causes (alcohol intake \>50 g/day women or \>60 g/day men
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beni Suef University Coordinator of this site? Confirm its status | Banī Suwayf | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.